APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Contract Service Outsourcing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical Contract Service Outsourcing Market Outlook and Growth Opportunities 2026

Report ID 17421428046 March 2026202 pages

Choose your research edition.

Industry ResearchPharmaceutical Contract Service Outsourcing Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Contract Service Outsourcing Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Contract Service Outsourcing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Contract Service Outsourcing Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Contract Service Outsourcing Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Pharmaceutical Contract Service Outsourcing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceutical Contract Service Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Contract Service Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Contract Service Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceutical Contract Service Outsourcing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceutical Contract Service Outsourcing market include Charles River, IQVIA, Lonza, PPD, ICON Plc, Inotiv, Labcorp, Eurofins Scientific and JOINN Lab, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pharmaceutical Contract Service Outsourcing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Contract Service Outsourcing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Contract Service Outsourcing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical Contract Service Outsourcing market.

Pharmaceutical Contract Service Outsourcing Segment by Company

Charles River

IQVIA

Lonza

PPD

ICON Plc

Inotiv

Labcorp

Eurofins Scientific

JOINN Lab

EVOTEC

EVERSANA

Amplity Health

Tigermed

ChemPartner

Medicilon

WuXi AppTec

China Medical System

Sinco Pharma

Pharmaceutical Contract Service Outsourcing Segment by Type

CRO

CMO

CDMO

CSO

Pharmaceutical Contract Service Outsourcing Segment by Application

Pharmaceutical Company

Biotechnology Company

Others

Pharmaceutical Contract Service Outsourcing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical Contract Service Outsourcing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmaceutical Contract Service Outsourcing key companies, revenue, market share, and recent developments.

3. To split the Pharmaceutical Contract Service Outsourcing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmaceutical Contract Service Outsourcing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical Contract Service Outsourcing significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical Contract Service Outsourcing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Contract Service Outsourcing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Contract Service Outsourcing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Contract Service Outsourcing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Contract Service Outsourcing industry.

Chapter 3: Detailed analysis of Pharmaceutical Contract Service Outsourcing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmaceutical Contract Service Outsourcing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmaceutical Contract Service Outsourcing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Contract Service Outsourcing Industry Trends Table 2. Pharmaceutical Contract Service Outsourcing Industry Drivers Table 3. Pharmaceutical Contract Service Outsourcing Industry Opportunities and Challenges Table 4. Pharmaceutical Contract Service Outsourcing Industry Restraints Table 5. Global Pharmaceutical Contract Service Outsourcing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Contract Service Outsourcing Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical Contract Service Outsourcing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmaceutical Contract Service Outsourcing Key Company Manufacturing Base & Headquarters Table 9. Global Pharmaceutical Contract Service Outsourcing Company, Product Type & Application Table 10. Global Pharmaceutical Contract Service Outsourcing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmaceutical Contract Service Outsourcing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of CRO Table 15. Significant Companies of CMO Table 16. Significant Companies of CDMO Table 17. Significant Companies of CSO Table 18. Global Pharmaceutical Contract Service Outsourcing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Pharmaceutical Contract Service Outsourcing Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Pharmaceutical Contract Service Outsourcing Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Pharmaceutical Contract Service Outsourcing Sales Value Share by Type (2021-2026) Table 22. Global Pharmaceutical Contract Service Outsourcing Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Pharmaceutical Company Table 24. Significant Companies of Biotechnology Company Table 25. Significant Companies of Others Table 26. Global Pharmaceutical Contract Service Outsourcing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pharmaceutical Contract Service Outsourcing Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Pharmaceutical Contract Service Outsourcing Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Pharmaceutical Contract Service Outsourcing Sales Value Share by Application (2021-2026) Table 30. Global Pharmaceutical Contract Service Outsourcing Sales Value Share by Application (2027-2032) Table 31. Global Pharmaceutical Contract Service Outsourcing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pharmaceutical Contract Service Outsourcing Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Pharmaceutical Contract Service Outsourcing Sales Value Share by Region (2021-2026) Table 34. Global Pharmaceutical Contract Service Outsourcing Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Pharmaceutical Contract Service Outsourcing Sales Value Share by Region (2027-2032) Table 36. Global Pharmaceutical Contract Service Outsourcing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Pharmaceutical Contract Service Outsourcing Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Pharmaceutical Contract Service Outsourcing Sales Value Market Share by Country (2021-2026) Table 39. Global Pharmaceutical Contract Service Outsourcing Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Pharmaceutical Contract Service Outsourcing Sales Value Market Share by Country (2027-2032) Table 41. Charles River Company Information Table 42. Charles River Business Overview Table 43. Charles River Pharmaceutical Contract Service Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Charles River Pharmaceutical Contract Service Outsourcing Product Portfolio Table 45. Charles River Recent Development Table 46. IQVIA Company Information Table 47. IQVIA Business Overview Table 48. IQVIA Pharmaceutical Contract Service Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. IQVIA Pharmaceutical Contract Service Outsourcing Product Portfolio Table 50. IQVIA Recent Development Table 51. Lonza Company Information Table 52. Lonza Business Overview Table 53. Lonza Pharmaceutical Contract Service Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Lonza Pharmaceutical Contract Service Outsourcing Product Portfolio Table 55. Lonza Recent Development Table 56. PPD Company Information Table 57. PPD Business Overview Table 58. PPD Pharmaceutical Contract Service Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. PPD Pharmaceutical Contract Service Outsourcing Product Portfolio Table 60. PPD Recent Development Table 61. ICON Plc Company Information Table 62. ICON Plc Business Overview Table 63. ICON Plc Pharmaceutical Contract Service Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. ICON Plc Pharmaceutical Contract Service Outsourcing Product Portfolio Table 65. ICON Plc Recent Development Table 66. Inotiv Company Information Table 67. Inotiv Business Overview Table 68. Inotiv Pharmaceutical Contract Service Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Inotiv Pharmaceutical Contract Service Outsourcing Product Portfolio Table 70. Inotiv Recent Development Table 71. Labcorp Company Information Table 72. Labcorp Business Overview Table 73. Labcorp Pharmaceutical Contract Service Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Labcorp Pharmaceutical Contract Service Outsourcing Product Portfolio Table 75. Labcorp Recent Development Table 76. Eurofins Scientific Company Information Table 77. Eurofins Scientific Business Overview Table 78. Eurofins Scientific Pharmaceutical Contract Service Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Eurofins Scientific Pharmaceutical Contract Service Outsourcing Product Portfolio Table 80. Eurofins Scientific Recent Development Table 81. JOINN Lab Company Information Table 82. JOINN Lab Business Overview Table 83. JOINN Lab Pharmaceutical Contract Service Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. JOINN Lab Pharmaceutical Contract Service Outsourcing Product Portfolio Table 85. JOINN Lab Recent Development Table 86. EVOTEC Company Information Table 87. EVOTEC Business Overview Table 88. EVOTEC Pharmaceutical Contract Service Outsourcing Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. EVOTEC Pharmaceutical Contract Service Outsourcing Product Portfolio Table 90. EVOTEC Recent Development Table 91. EVERSANA Company Information Table 92. EVERSANA Business Overview Table 93. EVERSANA Pharmaceutical Contract Service Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. EVERSANA Pharmaceutical Contract Service Outsourcing Product Portfolio Table 95. EVERSANA Recent Development Table 96. Amplity Health Company Information Table 97. Amplity Health Business Overview Table 98. Amplity Health Pharmaceutical Contract Service Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Amplity Health Pharmaceutical Contract Service Outsourcing Product Portfolio Table 100. Amplity Health Recent Development Table 101. Tigermed Company Information Table 102. Tigermed Business Overview Table 103. Tigermed Pharmaceutical Contract Service Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Tigermed Pharmaceutical Contract Service Outsourcing Product Portfolio Table 105. Tigermed Recent Development Table 106. ChemPartner Company Information Table 107. ChemPartner Business Overview Table 108. ChemPartner Pharmaceutical Contract Service Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. ChemPartner Pharmaceutical Contract Service Outsourcing Product Portfolio Table 110. ChemPartner Recent Development Table 111. Medicilon Company Information Table 112. Medicilon Business Overview Table 113. Medicilon Pharmaceutical Contract Service Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Medicilon Pharmaceutical Contract Service Outsourcing Product Portfolio Table 115. Medicilon Recent Development Table 116. WuXi AppTec Company Information Table 117. WuXi AppTec Business Overview Table 118. WuXi AppTec Pharmaceutical Contract Service Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. WuXi AppTec Pharmaceutical Contract Service Outsourcing Product Portfolio Table 120. WuXi AppTec Recent Development Table 121. China Medical System Company Information Table 122. China Medical System Business Overview Table 123. China Medical System Pharmaceutical Contract Service Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. China Medical System Pharmaceutical Contract Service Outsourcing Product Portfolio Table 125. China Medical System Recent Development Table 126. Sinco Pharma Company Information Table 127. Sinco Pharma Business Overview Table 128. Sinco Pharma Pharmaceutical Contract Service Outsourcing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Sinco Pharma Pharmaceutical Contract Service Outsourcing Product Portfolio Table 130. Sinco Pharma Recent Development Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Pharmaceutical Contract Service Outsourcing Product Image Figure 2. Global Pharmaceutical Contract Service Outsourcing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Contract Service Outsourcing Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Contract Service Outsourcing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. CRO Image Figure 8. CMO Image Figure 9. CDMO Image Figure 10. CSO Image Figure 11. Global Pharmaceutical Contract Service Outsourcing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Pharmaceutical Contract Service Outsourcing Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Pharmaceutical Contract Service Outsourcing Sales Value Share by Type (2021-2032) Figure 14. Pharmaceutical Company Image Figure 15. Biotechnology Company Image Figure 16. Others Image Figure 17. Global Pharmaceutical Contract Service Outsourcing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pharmaceutical Contract Service Outsourcing Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Pharmaceutical Contract Service Outsourcing Sales Value Share by Application (2021-2032) Figure 20. Global Pharmaceutical Contract Service Outsourcing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Pharmaceutical Contract Service Outsourcing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Pharmaceutical Contract Service Outsourcing Sales Value (2021-2032) & (US$ Million) Figure 23. North America Pharmaceutical Contract Service Outsourcing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Pharmaceutical Contract Service Outsourcing Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Pharmaceutical Contract Service Outsourcing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Pharmaceutical Contract Service Outsourcing Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Pharmaceutical Contract Service Outsourcing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Pharmaceutical Contract Service Outsourcing Sales Value (2021-2032) & (US$ Million) Figure 29. South America Pharmaceutical Contract Service Outsourcing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Pharmaceutical Contract Service Outsourcing Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Pharmaceutical Contract Service Outsourcing Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • CRO
  • CMO
  • CDMO
  • CSO
Applications
  • Pharmaceutical Company
  • Biotechnology Company
  • Others
Companies covered
  • Charles River
  • IQVIA
  • Lonza
  • PPD
  • ICON Plc
  • Inotiv
  • Labcorp
  • Eurofins Scientific
  • JOINN Lab
  • EVOTEC
  • EVERSANA
  • Amplity Health
  • Tigermed
  • ChemPartner
  • Medicilon
  • WuXi AppTec
  • China Medical System
  • Sinco Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceutical Contract Service Outsourcing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceutical Contract Service Outsourcing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmaceutical Contract Service Outsourcing Market Dynamics
  1. 2.1 Pharmaceutical Contract Service Outsourcing Industry Trends
  2. 2.2 Pharmaceutical Contract Service Outsourcing Industry Drivers
  3. 2.3 Pharmaceutical Contract Service Outsourcing Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Contract Service Outsourcing Industry Restraints
3 Pharmaceutical Contract Service Outsourcing Market by Company
  1. 3.1 Global Pharmaceutical Contract Service Outsourcing Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical Contract Service Outsourcing Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical Contract Service Outsourcing Company Ranking (2024-2026)
  4. 3.4 Global Pharmaceutical Contract Service Outsourcing Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmaceutical Contract Service Outsourcing Company Product Type and Application
  6. 3.6 Global Pharmaceutical Contract Service Outsourcing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmaceutical Contract Service Outsourcing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmaceutical Contract Service Outsourcing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical Contract Service Outsourcing Market by Type
  1. 4.1 Pharmaceutical Contract Service Outsourcing Type Introduction
  2. 4.1.1 CRO
  3. 4.1.2 CMO
  4. 4.1.3 CDMO
  5. 4.1.4 CSO
  6. 4.2 Global Pharmaceutical Contract Service Outsourcing Sales Value by Type
  7. 4.2.1 Global Pharmaceutical Contract Service Outsourcing Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pharmaceutical Contract Service Outsourcing Sales Value by Type (2021-2032)
  9. 4.2.3 Global Pharmaceutical Contract Service Outsourcing Sales Value Share by Type (2021-2032)
5 Pharmaceutical Contract Service Outsourcing Market by Application
  1. 5.1 Pharmaceutical Contract Service Outsourcing Application Introduction
  2. 5.1.1 Pharmaceutical Company
  3. 5.1.2 Biotechnology Company
  4. 5.1.3 Others
  5. 5.2 Global Pharmaceutical Contract Service Outsourcing Sales Value by Application
  6. 5.2.1 Global Pharmaceutical Contract Service Outsourcing Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharmaceutical Contract Service Outsourcing Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pharmaceutical Contract Service Outsourcing Sales Value Share by Application (2021-2032)
6 Pharmaceutical Contract Service Outsourcing Regional Value Analysis
  1. 6.1 Global Pharmaceutical Contract Service Outsourcing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Contract Service Outsourcing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Contract Service Outsourcing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical Contract Service Outsourcing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical Contract Service Outsourcing Sales Value (2021-2032)
  7. 6.3.2 North America Pharmaceutical Contract Service Outsourcing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmaceutical Contract Service Outsourcing Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmaceutical Contract Service Outsourcing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmaceutical Contract Service Outsourcing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmaceutical Contract Service Outsourcing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmaceutical Contract Service Outsourcing Sales Value (2021-2032)
  16. 6.6.2 South America Pharmaceutical Contract Service Outsourcing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmaceutical Contract Service Outsourcing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmaceutical Contract Service Outsourcing Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Contract Service Outsourcing Country-level Value Analysis
  1. 7.1 Global Pharmaceutical Contract Service Outsourcing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical Contract Service Outsourcing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmaceutical Contract Service Outsourcing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmaceutical Contract Service Outsourcing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmaceutical Contract Service Outsourcing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmaceutical Contract Service Outsourcing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmaceutical Contract Service Outsourcing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Charles River
  2. 8.1.1 Charles River Company Information
  3. 8.1.2 Charles River Business Overview
  4. 8.1.3 Charles River Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Charles River Pharmaceutical Contract Service Outsourcing Product Portfolio
  6. 8.1.5 Charles River Recent Developments
  7. 8.2 IQVIA
  8. 8.2.1 IQVIA Company Information
  9. 8.2.2 IQVIA Business Overview
  10. 8.2.3 IQVIA Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 IQVIA Pharmaceutical Contract Service Outsourcing Product Portfolio
  12. 8.2.5 IQVIA Recent Developments
  13. 8.3 Lonza
  14. 8.3.1 Lonza Company Information
  15. 8.3.2 Lonza Business Overview
  16. 8.3.3 Lonza Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Lonza Pharmaceutical Contract Service Outsourcing Product Portfolio
  18. 8.3.5 Lonza Recent Developments
  19. 8.4 PPD
  20. 8.4.1 PPD Company Information
  21. 8.4.2 PPD Business Overview
  22. 8.4.3 PPD Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 PPD Pharmaceutical Contract Service Outsourcing Product Portfolio
  24. 8.4.5 PPD Recent Developments
  25. 8.5 ICON Plc
  26. 8.5.1 ICON Plc Company Information
  27. 8.5.2 ICON Plc Business Overview
  28. 8.5.3 ICON Plc Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ICON Plc Pharmaceutical Contract Service Outsourcing Product Portfolio
  30. 8.5.5 ICON Plc Recent Developments
  31. 8.6 Inotiv
  32. 8.6.1 Inotiv Company Information
  33. 8.6.2 Inotiv Business Overview
  34. 8.6.3 Inotiv Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Inotiv Pharmaceutical Contract Service Outsourcing Product Portfolio
  36. 8.6.5 Inotiv Recent Developments
  37. 8.7 Labcorp
  38. 8.7.1 Labcorp Company Information
  39. 8.7.2 Labcorp Business Overview
  40. 8.7.3 Labcorp Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Labcorp Pharmaceutical Contract Service Outsourcing Product Portfolio
  42. 8.7.5 Labcorp Recent Developments
  43. 8.8 Eurofins Scientific
  44. 8.8.1 Eurofins Scientific Company Information
  45. 8.8.2 Eurofins Scientific Business Overview
  46. 8.8.3 Eurofins Scientific Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Eurofins Scientific Pharmaceutical Contract Service Outsourcing Product Portfolio
  48. 8.8.5 Eurofins Scientific Recent Developments
  49. 8.9 JOINN Lab
  50. 8.9.1 JOINN Lab Company Information
  51. 8.9.2 JOINN Lab Business Overview
  52. 8.9.3 JOINN Lab Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 JOINN Lab Pharmaceutical Contract Service Outsourcing Product Portfolio
  54. 8.9.5 JOINN Lab Recent Developments
  55. 8.10 EVOTEC
  56. 8.10.1 EVOTEC Company Information
  57. 8.10.2 EVOTEC Business Overview
  58. 8.10.3 EVOTEC Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 EVOTEC Pharmaceutical Contract Service Outsourcing Product Portfolio
  60. 8.10.5 EVOTEC Recent Developments
  61. 8.11 EVERSANA
  62. 8.11.1 EVERSANA Company Information
  63. 8.11.2 EVERSANA Business Overview
  64. 8.11.3 EVERSANA Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 EVERSANA Pharmaceutical Contract Service Outsourcing Product Portfolio
  66. 8.11.5 EVERSANA Recent Developments
  67. 8.12 Amplity Health
  68. 8.12.1 Amplity Health Company Information
  69. 8.12.2 Amplity Health Business Overview
  70. 8.12.3 Amplity Health Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Amplity Health Pharmaceutical Contract Service Outsourcing Product Portfolio
  72. 8.12.5 Amplity Health Recent Developments
  73. 8.13 Tigermed
  74. 8.13.1 Tigermed Company Information
  75. 8.13.2 Tigermed Business Overview
  76. 8.13.3 Tigermed Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Tigermed Pharmaceutical Contract Service Outsourcing Product Portfolio
  78. 8.13.5 Tigermed Recent Developments
  79. 8.14 ChemPartner
  80. 8.14.1 ChemPartner Company Information
  81. 8.14.2 ChemPartner Business Overview
  82. 8.14.3 ChemPartner Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 ChemPartner Pharmaceutical Contract Service Outsourcing Product Portfolio
  84. 8.14.5 ChemPartner Recent Developments
  85. 8.15 Medicilon
  86. 8.15.1 Medicilon Company Information
  87. 8.15.2 Medicilon Business Overview
  88. 8.15.3 Medicilon Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Medicilon Pharmaceutical Contract Service Outsourcing Product Portfolio
  90. 8.15.5 Medicilon Recent Developments
  91. 8.16 WuXi AppTec
  92. 8.16.1 WuXi AppTec Company Information
  93. 8.16.2 WuXi AppTec Business Overview
  94. 8.16.3 WuXi AppTec Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2021-2026)
  95. 8.16.4 WuXi AppTec Pharmaceutical Contract Service Outsourcing Product Portfolio
  96. 8.16.5 WuXi AppTec Recent Developments
  97. 8.17 China Medical System
  98. 8.17.1 China Medical System Company Information
  99. 8.17.2 China Medical System Business Overview
  100. 8.17.3 China Medical System Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2021-2026)
  101. 8.17.4 China Medical System Pharmaceutical Contract Service Outsourcing Product Portfolio
  102. 8.17.5 China Medical System Recent Developments
  103. 8.18 Sinco Pharma
  104. 8.18.1 Sinco Pharma Company Information
  105. 8.18.2 Sinco Pharma Business Overview
  106. 8.18.3 Sinco Pharma Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Sinco Pharma Pharmaceutical Contract Service Outsourcing Product Portfolio
  108. 8.18.5 Sinco Pharma Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst